Evidence map›Paper›PMID 26335311›Full record

ReviewCurrent opinion in clinical nutrition and metabolic care2015

Sirtuin-dependent clock control: new advances in metabolism, aging and cancer.

Selma Masri

Abstract readReview
In one paragraph

Review in Current opinion in clinical nutrition and metabolic care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Acrolein-triggered atherosclerosisJournal of biomedical research · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. NADSignal transduction and targeted therapy · 2021
    Review
  18. Review
  19. Metabolic implications of circadian disruption.Pflugers Archiv : European journal of physiology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Selma MasriDepartment of Biological Chemistry, Center for Epigenetics and Metabolism, University of California, Irvine, California, USA.
University of California, Irvine · US

Funding

The Role of SIRT6 in Modulating Circadian Gene ExpressionF32GM097899 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI MASRI, SELMA · 2011 to 2012
$105k
NIGMS NIH HHS F32 GM097899
6 · The paper itself

Abstract

purpose of reviewThe circadian clock is an intricate biological timekeeper that is subject to fine-tuning mechanisms in order to maintain synchrony with the surrounding environment. One such mechanism is performed by the mammalian sirtuins that provide plasticity to the circadian clock by sensing cellular metabolic state. The sirtuins modulate the circadian epigenome and subsequent transcriptional control, and alterations to this organized system manifest in metabolic consequences, aging phenotypes and possibly cancer. RECENT

findingsNew information regarding sirtuin-dependent control of the circadian clock has emerged. In addition to sirtuin (SIRT)1 and SIRT3, SIRT6 has been demonstrated as a critical regulator of circadian transcription that also serves as an interface with metabolic homeostasis. Also, new metabolic functions of SIRT1 have been described in the brain, which are critical to relay nutritional inputs to the central clock. SUMMARY: This review focuses on the link between the circadian clock and the sirtuins, with an emphasis on new findings. In addition, speculation on the possible connections at the physiological level will be made that could further link the clock to aging and cancer.

Indexed as

AgingCircadian ClocksCircadian RhythmAnimalsCLOCK ProteinsHumansNeoplasmsNutritional StatusSirtuinsCLOCK ProteinsSirtuins

Identifiers

PMID26335311
PMCPMC4610809
OpenAlexW1215975020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.